Chewy
CHWY NYSE· Other Specialty Retail
Last close · Oct 26, 2026
$21.90
KIRA · Stoqly’s AI analyst, in plain words
- Chewy had $12.6B of revenue in fiscal 2025, up 6.2% on the year before. Over five years, revenue changed +12.0% a year on average.
- Its operating margin was 2.0%, up 1.1 pts: of every 100 in sales, about 2 is left after running the business.
- Chewy made $223M of net profit in fiscal 2025.
- Free cash flow was $562M in fiscal 2025, 4.5% of revenue.
- Chewy returned $263M to shareholders in fiscal 2025, 47% of free cash flow. The diluted share count fell 1.2%.
- Chewy has $879M more cash than debt.
Market cap
$9.0B
P/E
33.2x
Revenue
$12.6B
Net income
$223M
Free cash flow
$562M
Operating margin
2.0%
Chewy in 30 seconds · fiscal 2025
Are sales growing?
+6.2%
Yes. Sales grew 6.2% last year.
Does it make a profit?
1.8%
A little. It keeps 1.8% of every sale as profit.
Does profit turn into cash?
4.5%
Partly. 4.5% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
7 / 9
Solid. It passes 7 of 9 health tests.
How is the share priced?
33.2x
One share costs 33.2 times its yearly profit per share. Typical for its sector: 17.7x.
What Chewy does
Chewy is an online pet retailer. Through its websites and mobile apps it sells pet food, treats, supplies and medications to pet owners in the United States and Canada. It carries about 4,000 brands and about 190,000 products and services, including its own private brands such as Frisco and American Journey. Many customers sign up for Autoship, a subscription that delivers items on a regular schedule. Most of its revenue comes from selling products online. Chewy also earns money from pet health services: it runs a pharmacy, a telehealth service called Connect with a Vet, pet insurance and wellness plans called CarePlus, and a growing number of veterinary clinics under the name Chewy Vet Care (18 at the end of 2025). It also sells advertising to its vendor partners and offers PracticeHub, a tool that lets vet practices sell through Chewy. Chewy ships from fulfillment centers in the US and Canada and says it can serve over 80% of the US population overnight.
Biggest risks, in its own words
- Failing to win and keep customers at a reasonable cost.
- Depending on suppliers and on shipping and fulfillment centers to deliver orders on time.
- Strong competition in pet products, especially from online sellers.
- Veterinarians who may resist prescriptions or discourage pet owners from buying from it.
- Fiscal year ends
- February 1, 2026
- Latest annual report
- 10-K · Mar 25, 2026
- Legal name
- Chewy, Inc.
- CIK
- 0001766502
Chewy · CHWY
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $9.0B | $10.1B | $11.1B | $11.9B | $12.6B |
| Revenue growth | 25.5% | 12.8% | 10.2% | 6.4% | 6.2% |
| Gross margin | 26.6% | 28.0% | 28.4% | 29.2% | 29.8% |
| Operating margin | −0.8% | 0.6% | −0.2% | 1.0% | 2.0% |
| Net income | −$75.2M | $49.9M | $39.6M | $393M | $223M |
| Net margin | −0.8% | 0.5% | 0.4% | 3.3% | 1.8% |
| Diluted EPS | −$0.18 | $0.12 | $0.09 | $0.91 | $0.52 |
| Cash | |||||
| Cash from operations | $192M | $350M | $486M | $596M | $692M |
| Capital expenditure | $183M | $230M | $143M | $144M | $129M |
| Free cash flow | $8.6M | $119M | $343M | $453M | $562M |
| FCF margin | 0.1% | 1.2% | 3.1% | 3.8% | 4.5% |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $943M | $263M |
| Share count change | 2.5% | 2.5% | 1.0% | −0.2% | −1.2% |
| Debt and strength | |||||
| Cash and short-term investments | $603M | $679M | $1.1B | $597M | $879M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | −$39.6M | $160M | $510M | $262M | $498M |
| Net debt / EBITDA | — | −4.9x | −13.2x | −2.6x | −2.3x |
| Current ratio | 0.8x | 0.8x | 1.0x | 0.8x | 0.9x |
| Interest coverage | −34.0x | 21.9x | −6.6x | 20.4x | 55.3x |
| Returns and quality | |||||
| Return on equity | — | — | 11.8% | 101.8% | 58.7% |
| Piotroski F-score | 4 | 6 | 5 | 6 | 7 |
| Altman Z'' | −4.4 | −3.2 | −1.9 | −2.6 | −1.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$7.3M
5 insiders
Of sales under plans
96%
$7.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Chewy · CHWY
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Chewy CHWY | $9.0B | 6.2% | 2.0% | 4.5% | — | 33.2x | 7 |
| Ulta Beauty ULTA | $27.0B | 9.7% | 12.4% | 8.6% | 55.8% | 22.8x | 6 |
| Tractor Supply TSCO | $17.1B | 4.3% | 9.5% | 4.8% | 28.5% | 16.9x | 6 |
| Bath & Body Works BBWI | $4.3B | −0.2% | 15.4% | 11.9% | 47.5% | 5.6x | 5 |
| Winmark WINA | $1.0B | 5.9% | 63.4% | 52.0% | — | 25.0x | — |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $21.90 a share, the company is worth $9.0B: 33.2 times its earnings of the last four quarters.
Chewy grew sales faster than 3 of its 4 similar companies. Its P/E is higher than 4 of 4.
Source: SEC EDGAR XBRL filings (CIK 0001766502). Data updated October 9, 2026. For information only — not investment advice. Check the original filings before relying on any figure.